Test Price
2,700 AED✅ Home Collection Available
Eosinophilic Leukemia FISH Panel in UAE – 2,700 AED – DHA Licensed Laboratory
Executive Summary & Core Metrics
Clinical & Service Highlights
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified laboratory processing – results trusted by DHA-registered oncologists and hematologists.
- Sample Collection: Hospital Extraction Only – Procedure requires bone marrow or peripheral blood collection in an accredited hospital facility; mobile home phlebotomy is not available for this test. Secure cold-chain transport handled by the hospital.
- Clinical Guidance: Complimentary telephonic post‑test clinical correlation session to translate FISH findings into actionable treatment decisions.
- Insurance Direct Billing: Verify your coverage instantly via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Eosinophilic Leukemia FISH Panel uses Fluorescence In‑Situ Hybridization to detect cryptic rearrangements in PDGFRA, PDGFRB, FGFR1, and PCM1‑JAK2 – critical biomarkers that define eosinophilic myeloid/lymphoid neoplasms and dictate targeted therapy with tyrosine kinase inhibitors such as imatinib.
| Feature | Our Eosinophilic Leukemia FISH Panel | Alternative (Conventional Cytogenetics) |
|---|---|---|
| Target Resolution | Single‑cell, locus‑specific detection of submicroscopic rearrangements | Karyotype banding; misses cryptic 4q12 or 5q31‑33 lesions |
| Turnaround Time | 3–4 days (ready for rapid clinical decision‑making) | 7–14 days, often requires culture step |
| Clinical Actionability | Directly qualifies patient for imatinib therapy if PDGFRA/PDGFRB‑positive | Limited; must refer to FISH or reverse‑transcriptase PCR |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I confirm that this FISH panel provides definitive evidence of eosinophilic leukemia subtypes. However, it must always be interpreted within the full clinical picture – including blood counts, symptoms, and bone marrow morphology – never in isolation. Your treating physician will correlate these genetic findings with your personal history to craft a safe, tailored treatment plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Do not discontinue any prescribed medication, especially corticosteroids or tyrosine kinase inhibitors, without consulting your physician. Abrupt cessation can trigger severe disease flares.
Patient Exclusion Criteria & Emergency Red Flags
- Do not schedule hospital collection if you have active, uncontrolled bleeding or known hemodynamic instability – seek immediate hospital care.
- This test requires a bone marrow or peripheral blood sample; patients with severe coagulopathy or platelet count <20×10⁹/L must be assessed in a hospital setting.
- If you experience sudden vision loss, splenic infarction pain (left shoulder/abdominal), or neurological symptoms such as seizures, go to the nearest emergency department – these may indicate leukostasis.
- ER Red Flag: Respiratory distress, altered mental status, or signs of stroke – dial 998 and inform the team of your suspected hematological condition.
Patient FAQ & Clinical Guidance
1. What does the eosinophilic leukemia FISH panel detect?
The panel identifies rearrangements of PDGFRA, PDGFRB, FGFR1, and PCM1‑JAK2 genes at the single‑cell level, confirming the World Health Organization‑defined myeloid/lymphoid neoplasms with eosinophilia.
2. How is the sample collected?
A DHA‑licensed healthcare professional collects bone marrow aspirate or peripheral blood during a sterile procedure in a hospital setting. Results are delivered within 3–4 working days.
3. Is a doctor’s prescription mandatory for this test?
A valid doctor’s prescription is required, except when the test is performed for pre‑surgical clearance, pregnancy‑related evaluation, or travel abroad planning.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
Your health data is protected under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent comply with Federal Decree‑Law No. 4 of 2016 on Medical Liability. All testing is performed in a DHA‑licensed facility (License No. 1143) adhering to international quality standards.
Clinical & Logistical Metadata
| Test Name | Eosinophilic Leukemia FISH Panel |
| Price (AED) | 2,700 |
| Turnaround Time | 3–4 working days |
| Sample Type / Matrix | Bone Marrow Aspirate / Peripheral Blood (Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.) |
| Methodology Used | Fluorescence In Situ Hybridization (FISH) |
| ICD-10-CM Code | C94.7 |
| LOINC Code | 57712-2 |
| DHA Facility License & Laboratory Address | 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians